␣-Synuclein is present in Lewy bodies of patients with both sporadic and familial Parkinson's disease. However, pathogenic mutations Ala30Pro and Ala53Thr in ␣-synuclein are rare causes of disease. Synphilin-1 has been demonstrated to associate with ␣-synuclein and promote the formation of cytosolic inclusions in vitro. Two-point genetic linkage analysis of a dinucleotide repeat within the synphilin-1 gene initially implicated this locus as a cause of Parkinson's disease in three of nine families. However, subsequent haplotype, sequencing, and association analyses in these three families and an independent case-control series suggest that variability within the locus does not confer susceptibility to Parkinson's disease.
INTRODUCTION
Charcot's student, Leroux (1880) , reported "Une cause vraie de la paralysie agitante et peut-être la seule vraie, c'est l'hérédité" ("The one true cause of paralysis agitans and perhaps the only truth is heredity"). Today, more than a century later this remains the case, with a single gene, ␣-synuclein, now recognized (Polymeropoulos et al., 1997) as one of the pathogenic loci, and two genetic linkages, one on chromosome 2p13 (Gasser et al., 1998) and the other on chromosome 4p15 (Farrer et al., 1999a) , reported but not yet identified. However, these loci do not account for all the familial clustering of Parkinson's disease (PD) and there are clearly other genetic loci yet to be identified (Vaughan et al., 1998; Lincoln et al., 1999a,b; Gwinn-Hardy et al., in press ).
␣-Synuclein is a major component of Lewy bodies (Spillantini et al., 1998) , which are the pathologic substrate of PD. It appears likely that other genes involved in the etiology of PD will be involved in the formation of these lesions, perhaps through their interaction with ␣-synuclein.
Recently, using a yeast two-hybrid screen, Engelender et al. (1999a) identified a novel protein, synphilin-1, that interacts with ␣-synuclein in vitro. Cotransfection of synphilin-1 and ␣-synuclein genes into cells led to the deposition of eosinophilic inclusions that resembled Lewy bodies. Furthermore, antibodies raised to synphilin-1 show robust staining of Lewy bodies in brains of patients with PD or dementia with Lewy bodies (Engelender et al., 1999b) .
Therefore, synphilin-1 is an excellent candidate gene for those cases of familial PD not accounted for by established loci. We report the genetic analysis of the synphilin-1 locus using complementary linkage and association methods.
